Francesca Bruce

Francesca Bruce

Senior Writer

Newcastle, UK

Francesca writes about a broad range of policy and regulatory topics, including intellectual property rights. However, her main areas of expertise are pricing and reimbursement and how medicines may or may not make it to patients. She writes about developments in Europe and is also expanding coverage in emerging markets, including Latin America and the Middle East. Francesca writes for Pink Sheet, Scrip and In Vivo.

Latest from Francesca Bruce

Nordic Medtech Experts Urge More Collaboration On Health Technology Assessments

European cross-country HTA collaborations have much to learn from each other to keep prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

EU HTA Reg: CoI Rules Limit Participation Of Experts In Joint Clinical Assessments

The European Commission has now adopted the third implementing act for the Health Technology Assessment Regulation. This sets out rules for managing conflicts of interest of anyone involved in joint clinical assessments or joint scientific consultations under the regulation.

Cross-Country HTA Collaboration To Focus On Health Economics & RWE

European cross-country HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

Nordic HTA Body Tells Pharma Users: ‘Feel the Fear And Do It Anyway’

It is time for companies to take part in cross-country health technology assessments and stop only asking “what’s in it for me?”

Urgent Review Of EU Urban Wastewater Treatment Directive Unlikely, Despite Industry Concerns

The updated directive could risk the supply of critical medicines and fail to incentivize greener product development more generally, warns European industry group EFPIA.

New Pharma Research Law Fails To Make Germany More Competitive Says EUCOPE Head

Germany’s Medical Research Act clears its final legal hurdle after federal council sign off.